Profound Medical Corp. (PROF)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	169	225	202	223	234	403
Market Cap Growth	-16.71%	11.58%	-9.56%	-4.57%	-41.98%	199.27%
Enterprise Value	126	206	176	178	163	318
Last Close Price	5.50	7.51	8.49	10.89	11.23	20.56
PS Ratio	14.28	21.10	28.06	33.43	34.05	55.23
PB Ratio	3.34	3.73	6.47	4.30	2.90	4.14
P/TBV Ratio	3.35	3.75	6.57	4.35	3.06	4.35
EV/Sales Ratio	10.64	19.27	24.43	26.58	23.77	43.61
Debt / Equity Ratio	0.10	0.09	0.25	0.16	0.02	0.02
Asset Turnover	0.20	0.19	0.13	0.09	0.07	0.11
Inventory Turnover	0.56	0.57	0.39	0.48	0.62	0.85
Quick Ratio	9.90	9.44	5.26	12.63	16.50	18.99
Current Ratio	11.32	10.52	6.58	14.82	18.56	20.33
Return on Equity (ROE)	-66.36%	-60.70%	-68.06%	-43.23%	-34.50%	-38.71%
Return on Assets (ROA)	-38.54%	-36.19%	-33.05%	-24.47%	-19.79%	-17.51%
Return on Capital (ROIC)	-41.94%	-39.50%	-36.06%	-26.02%	-20.92%	-18.96%
Earnings Yield	-18.86%	-12.34%	-14.02%	-12.84%	-13.12%	-5.36%
FCF Yield	-16.06%	-10.41%	-11.19%	-11.55%	-9.57%	-5.10%
Buyback Yield / Dilution	-18.96%	-16.91%	-1.69%	-1.79%	-18.33%	-55.83%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q